Evidence map›Paper›PMID 23176180›Full record

ArticleBMC cancer2012

Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231.

Arturo Aguilar-Rojas, Maira Huerta-Reyes, Guadalupe Maya-Núñez, Fabián Arechavaleta-Velásco, P Michael Conn, Alfredo Ulloa-Aguirre, Jesús Valdés

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. A partial loss-of-function variant inTranslational andrology and urology · 2021
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Roles of Ras Homolog A in Invasive Ductal Breast Carcinoma.Acta histochemica et cytochemica · 2016
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Arturo Aguilar-RojasCentro de Investigación Biomédica del Sur (CIBIS), Instituto Mexicano del Seguro Social (IMSS), Argentina No, 1, Col, Centro, 62790, Xochitepec, Morelos, Mexico. a_aguilar@unam.mx
Maira Huerta-Reyes
Guadalupe Maya-Núñez
Fabián Arechavaleta-Velásco
P Michael Conn
Alfredo Ulloa-Aguirre
Jesús Valdés
Hospital de Especialidades · MXMexican Social Security Institute · MXCenter for Research and Advanced Studies of the National Polytechnic Institute · MXInstituto Nacional de Salud Pública · MXOregon National Primate Research Center · US

Funding

High Throughput Screening Assay Development for PharmacoperonesR01DK085040 · NIDDK · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI CONN, P. MICHAEL · 2010 to 2012
$1.1M
Mouse Model for Diseases of Protein MisfoldingR21OD012220 · OD · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI CONN, P. MICHAEL · 2012 to 2012
$213k
NIDDK NIH HHS R01 DK085040NIH HHS R21 OD012220
6 · The paper itself

Abstract

backgroundGonadotropin-releasing hormone (GnRH) and its receptor (GnRHR) are both expressed by a number of malignant tumors, including those of the breast. In the latter, both behave as potent inhibitors of invasion. Nevertheless, the signaling pathways whereby the activated GnRH/GnRHR system exerts this effect have not been clearly established. In this study, we provide experimental evidence that describes components of the mechanism(s) whereby GnRH inhibits breast cancer cell invasion.

methodsActin polymerization and substrate adhesion was measured in the highly invasive cell line, MDA-MB-231 transiently expressing the wild-type or mutant DesK191 GnRHR by fluorometry, flow cytometric analysis, and confocal microscopy, in the absence or presence of GnRH agonist. The effect of RhoA-GTP on stress fiber formation and focal adhesion assembly was measured in MDA-MB-231 cells co-expressing the GnRHRs and the GAP domain of human p190Rho GAP-A or the dominant negative mutant GAP-Y1284D. Cell invasion was determined by the transwell migration assay.

resultsAgonist-stimulated activation of the wild-type GnRHR and the highly plasma membrane expressed mutant GnRHR-DesK191 transiently transfected to MDA-MB-231 cells, favored F-actin polymerization and substrate adhesion. Confocal imaging allowed detection of an association between F-actin levels and the increase in stress fibers promoted by exposure to GnRH. Pull-down assays showed that the effects observed on actin cytoskeleton resulted from GnRH-stimulated activation of RhoA GTPase. Activation of this small G protein favored the marked increase in both cell adhesion to Collagen-I and number of focal adhesion complexes leading to inhibition of the invasion capacity of MDA-MB-231 cells as disclosed by assays in Transwell Chambers.

conclusionsWe here show that GnRH inhibits invasion of highly invasive breast cancer-derived MDA-MB-231 cells. This effect is mediated through an increase in substrate adhesion promoted by activation of RhoA GTPase and formation of stress fibers and focal adhesions. These observations offer new insights into the molecular mechanisms whereby activation of overexpressed GnRHRs affects cell invasion potential of this malignant cell line, and provide opportunities for designing mechanism-based adjuvant therapies for breast cancer.

Indexed as

Cell MovementActinsBreast NeoplasmsBuserelinCell Line, TumorEnzyme ActivationFemaleFlow CytometryFluorometryFocal AdhesionsGonadotropin-Releasing HormoneHumansImmunoblottingMCF-7 CellsMicroscopy, ConfocalMutationActinsBuserelinGNRHR protein, humanGonadotropin-Releasing HormoneReceptors, LHRHrhoA GTP-Binding Protein

Identifiers

PMID23176180
PMCPMC3518142
OpenAlexW2116856159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.